SP1 and renal cell carcinoma: Furthermore, gain-of-function analyses of miR-362-3p in vitro and in vivo suggest that miR-362-3p was able to suppress the proliferation and metastasis of RCC cells via SP1/AKT/FOXO3 signaling.